Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis
ObjectiveTo compare the efficacy and safety of pharmaceutical interventions to prevent etomidate-induced myoclonus (EIM), providing the optimal intervention for clinical practice.MethodsPubMed, Embase, the Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, Chinese National Knowledge...
Saved in:
Main Authors: | Lu Chen, Pengxiang Zhou, Zhengqian Li, Ziyang Wu, Suodi Zhai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1507616/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-Induced Myoclonus: A Systematic Review
by: Jamir Pitton Rissardo, et al.
Published: (2025-01-01) -
Myoclonus
by: R. Rimšienė, et al.
Published: (2020-12-01) -
Clinical efficacy of low‐dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2
by: Antonietta Coppola, et al.
Published: (2025-02-01) -
The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
by: Fang He, et al.
Published: (2025-02-01) -
Paradoxical reactions to midazolam: A case report
by: Shenglin Chi, et al.
Published: (2025-02-01)